
New Cell Therapy Delivers Cancer Viruses to Tumours
Adults with solid tumours may one day benefit, but the approach has so far been tested only in mouse models.
For readers in Houston, this page covers research, treatment advances and screening guidelines. Reporting spans clinical trials, updates to diagnostic standards and findings on health risks.

Adults with solid tumours may one day benefit, but the approach has so far been tested only in mouse models.
November 6, 2026
MD Anderson Expansion Adds Capacity for Houston PatientsThe planned $3.4 billion project is projected to raise treatment capacity more than 25% by the early 2030s.
October 30, 2026
Leukemia Trial Reaches Key Milestone for PatientsThe study, which aims to help patients with relapsed leukemia, has completed its initial patient dosing phase.
October 25, 2026
Managing Breast Cancer Treatment ExpensesPatients facing a mastectomy and subsequent cancer care often encounter significant financial challenges.
October 22, 2026
New Model Maps Treatment Resistance in Colorectal CancerResearchers identified biological states linked to treatment outcomes, offering a potential path for future clinical insight.
October 21, 2026
Houston Child Receives Bone Marrow Transplant for CancerThe 7-year-old patient is recovering in the hospital following a donation from her sister to treat her leukemia.
October 13, 2026
Houston Program Provided Expanded Cervical ScreeningsThe Houston PAP Project offers local women no-cost cervical cancer screenings and necessary follow-up care.
October 10, 2026
Nursing Expert Discussed Living With Neurofibromatosis Type 1A Houston-based nursing specialist shared how patient-centered communication improves care for those with NF1.
October 7, 2026
Nerve Stimulation Device Trial Cleared for CachexiaHouston patients with pancreatic cancer may soon enroll in a new study testing a noninvasive device to treat cachexia.
October 7, 2026
Rockets Manager Announced Skin Cancer DiagnosisHannah Peery is raising awareness for skin cancer screenings and cancer research ahead of her upcoming surgery.
October 6, 2026
New Cerebrospinal Fluid Cancer Tests Will Launch October 12Houston patients and others in the U.S. will gain access to molecular profiling tests for CNS tumors and malignancies.
Houston reporting spans clinical trial results, treatment developments, screening recommendations and health studies. Coverage runs across the city and the communities around it, wherever care is delivered or research is conducted. Local health facilities and academic research centers often drive the pace of clinical trials and the adoption of new screening standards. Survivorship support and access to specialized centers remain the two factors that define the patient experience across the city.